Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment
Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
BioArctic and Mesenkia sign research collaboration for glioblastoma antibody project
Tolerance Bio licenses clinical-stage IL-7 therapy from NeoImmuneTech
Merck and Moderna report positive Phase 3 melanoma trial results
Scancell announces UK authorisation for Phase 3 melanoma trial
Harbour BioMed IND for HBM7004 approved by China's NMPA
Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study
Galmed reports positive preclinical results for Aramchol in prostate cancer
AstraZeneca reports positive Phase III results for Tagrisso and Orpathys
HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination
BioSapien nominated in 'Best Startup' category for 20th Prix Galien USA Awards